z-logo
open-access-imgOpen Access
Malaria vaccine deployment in Africa: focus on Ghana
Author(s) -
Kwaku Poku Asante,
Fred Binka,
Kwadwo A. Koram
Publication year - 2019
Publication title -
ghana medical journal
Language(s) - English
Resource type - Journals
eISSN - 2616-163X
pISSN - 0016-9560
DOI - 10.4314/gmj.v53i2.2
Subject(s) - malaria , medicine , christian ministry , ebola virus , software deployment , virology , malaria vaccine , economic growth , environmental health , family medicine , immunology , outbreak , plasmodium falciparum , political science , economics , law , computer science , operating system
The announcement by the Ghana Health Service /Ministry of Health at the beginning of May to begin the pilot implementation of the malaria vaccine – RTS,S/AS01 (Mosquirix®) – manufactured by GSK Biologicals was greeted with rumours about conspiracy theories of secret agenda to depopulate Africa through the use of vaccines and all the other stories that are often propagated by the anti vaxxers. This was not unlike the fear and panic spread throughout the country that prevented investigators from conducting clinical trials on new vaccines against the Ebola virus disease a few years ago.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom